Submit manuscript...
Journal of
eISSN: 2373-633X

Cancer Prevention & Current Research

Mini Review Volume 16 Issue 5

Thyroid dysfunction after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Noskova I, Spiliotis J, Spiliotis AE, Diamadis A, Apostolopoulos A

4th Department of Surgery and Surgical Oncology European Interbalkan Medical Center, Thessaloniki, Greece
Surgical Oncology Athens Medical Center, Athens, Greece
OncoSurgery IKE, Athens, Greece
Department of Surgery Medical School of Thessaly, Larisa, Greece
Department of Surgery Ygia Polyclinic, Limassol, Cyprus
Health Support IE, Athens, Greece

Received: November 29, 2025 | Published: December 18, 2025

Citation: Spiliotis J, Spiliotis AE, Diamadis A, et al. Thyroid dysfunction after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). J Cancer Prev Curr Res. 2025;16(5):140‒141 DOI: 10.15406/jcpcr.2025.16.00593

Download PDF

Abstract

Background: Cytoreductive surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) are complex procedures associated with significant morbidity and mortality. Thyroid dysfunction is increasingly recognized as a potential factor influencing postoperative outcomes.

Objective: This study aimed to evaluate the effect of CRS and HIPEC on thyroid hormone and cortisol levels, and their association with surgical outcomes.

Methods: Four hundred patients undergoing CRS and HIPEC for peritoneal metastases were included. Patients with thyroid or endocrine disorders were excluded. Serum levels of TSH, Free T3, Total T3, Free T4, Total T4, cortisol, and albumin were measured preoperatively, intraoperatively, and on postoperative days 3, 6, and 10. Statistical significance was assessed using the paired Student’s t-test.

Results: Free T3 and Total T3 levels were significantly decreased on the first and sixth postoperative days (p < 0.05). Cortisol levels increased significantly on postoperative days 4, 6, and 10 (p < 0.05), with the highest levels observed in patients with adverse events. TSH levels decreased initially but normalized progressively. Albumin levels dropped significantly during the first week. Free T4 and Total T4 showed no significant changes.

Conclusion: Thyroid dysfunction and cortisol response are common after CRS and HIPEC, with Free T3 levels correlating with shorter ICU and hospital stays, and TSH changes associated with prolonged recovery. Preoperative and perioperative thyroid assessment may optimize surgical outcomes.

Keywords: Chemotherapy,significant morbidity,mortality

Creative Commons Attribution License

©2025 Spiliotis, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.